Strides Pharma Science Limited has informed the Exchange regarding a press release dated January 30, 2024, titled "Strides reports strong Q3FY24 Revenue and EBITDA".
Strides Pharma Science Limited has informed the Exchange regarding a press release dated January 30, 2024, titled "Strides reports strong Q3FY24 Revenue and EBITDA".